OG
One68 Global Capital, LLC
13F filer · CIK 0001755535Reported Aug 17, 2026
Net buyer this quarter
13F portfolio value$47.2MU.S. long equity reported on 13F
Positions5440 new · 24 closed
Net flow last quarter+$14.2MBuys minus sells
Top 10 positions weight68.4%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Aug 17, 202654 positions | |||||
| $9.52M | 20.16% | 0.01% | +151.4% | Q1 2026 | |
| $6.83M | 14.46% | 0.16% | New | Q2 2026 | |
| CIGTLSChart Industries Inc | $4.37M | 9.26% | 0.04% | -3.2% | Q1 2026 |
| EAEAElectronic Arts Inc. | $2.99M | 6.34% | Not reported | +85.4% | Q1 2026 |
| $2.19M | 4.64% | 0.00% | New | Q2 2026 | |
| TBLDTopBuild Corp | $1.95M | 4.13% | 0.02% | New | Q2 2026 |
| $1.19M | 2.52% | 0.00% | -30.8% | Q1 2026 | |
| SMSEMSelect Medical Holdings Corp | $1.16M | 2.45% | 0.06% | New | Q2 2026 |
| $1.12M | 2.37% | 0.00% | New | Q2 2026 | |
| $975K | 2.07% | 0.01% | +65.9% | Q1 2026 | |
| TMTMHCTaylor Morrison Home Corp | $933K | 1.97% | 0.01% | New | Q2 2026 |
| $789K | 1.67% | 0.03% | Not reported | Q1 2025 | |
| $755K | 1.60% | 0.01% | New | Q2 2026 | |
| $691K | 1.46% | 0.01% | +166.7% | Q4 2024 | |
| SRSILASila Realty Trust, Inc. | $607K | 1.29% | 0.04% | New | Q2 2026 |
| $563K | 1.19% | Not reported | New | Q2 2026 | |
| $522K | 1.10% | 1000000.00% | New | Q2 2026 | |
| $500K | 1.06% | 0.00% | New | Q2 2026 | |
| $491K | 1.04% | 0.00% | New | Q2 2026 | |
| CPCPRXCatalyst Pharmaceuticals, Inc. | $471K | 1.00% | 0.01% | New | Q2 2026 |
| $465K | 0.98% | 0.00% | New | Q2 2026 | |
| $455K | 0.96% | 0.00% | New | Q2 2026 | |
| $454K | 0.96% | 0.02% | -40.0% | Q1 2025 | |
| $444K | 0.94% | Not reported | New | Q2 2026 | |
| $427K | 0.90% | 0.00% | New | Q2 2026 | |
| $414K | 0.88% | Not reported | New | Q2 2026 | |
| WRWSRWhitestone REIT | $379K | 0.80% | 0.04% | Not reported | Q4 2024 |
| $368K | 0.78% | Not reported | Not reported | Q1 2025 | |
| $349K | 0.74% | 0.00% | +112.5% | Q4 2024 | |
| $336K | 0.71% | 0.01% | New | Q2 2026 | |
| $329K | 0.70% | 0.05% | New | Q2 2026 | |
| $316K | 0.67% | 0.00% | New | Q2 2026 | |
| $298K | 0.63% | 0.00% | Not reported | Q1 2025 | |
| $292K | 0.62% | 0.00% | Not reported | Q1 2025 | |
| $284K | 0.60% | 0.01% | Not reported | Q4 2024 | |
| $283K | 0.60% | 0.00% | Not reported | Q4 2024 | |
| $282K | 0.60% | 0.00% | New | Q2 2026 | |
| BFBF.BBrown Forman Corp | $267K | 0.56% | 0.00% | New | Q2 2026 |
| $242K | 0.51% | 0.00% | +25.0% | Q4 2024 | |
| $229K | 0.48% | 0.01% | New | Q2 2026 | |
| $217K | 0.46% | 0.01% | New | Q2 2026 | |
| $200K | 0.42% | 0.00% | New | Q2 2026 | |
| $146K | 0.31% | 0.04% | Not reported | Q1 2025 | |
| $128K | 0.27% | 0.01% | -67.3% | Q4 2024 | |
| ETESPREsperion Therapeutics, Inc. | $94.8K | 0.20% | 0.01% | New | Q2 2026 |
| $93.6K | 0.20% | Not reported | Not reported | Q4 2025 | |
| $89.5K | 0.19% | 0.01% | -23.2% | Q4 2024 | |
| $77.2K | 0.16% | 0.08% | -52.9% | Q4 2025 | |
| $73.4K | 0.16% | 0.01% | Not reported | Q1 2026 | |
| $66.6K | 0.14% | 0.00% | New | Q2 2026 | |
| Q1 2026Reported May 15, 202638 positions | |||||
| CIGTLSChart Industries Inc | $4.47M | 14.47% | 0.05% | New | Q1 2026 |
| SASEESealed Air Corp | $4.14M | 13.40% | 0.07% | New | Q1 2026 |
| $3.9M | 12.63% | 0.01% | New | Q1 2026 | |
| APAPLSApellis Pharmaceuticals, Inc. | $2.23M | 7.21% | 0.04% | New | Q1 2026 |
| EAEAElectronic Arts Inc. | $1.61M | 5.20% | Not reported | New | Q1 2026 |
| $1.51M | 4.87% | 0.00% | New | Q1 2026 | |
| TPTPHTri Pointe Homes, Inc. | $1.3M | 4.20% | 0.03% | New | Q1 2026 |
| VRVREVeris Residential, Inc. | $1.13M | 3.66% | Not reported | New | Q1 2026 |
| HHOLXHologic Inc | $690K | 2.23% | 0.00% | New | Q1 2026 |
| $607K | 1.97% | 0.01% | New | Q1 2026 | |
| $584K | 1.89% | Not reported | New | Q1 2026 | |
| TPTERNTerns Pharmaceuticals, Inc. | $580K | 1.88% | 0.01% | New | Q1 2026 |
| $536K | 1.74% | 0.03% | +87.5% | Q1 2025 | |
| $482K | 1.56% | 0.00% | Not reported | Q1 2019 | |
| $408K | 1.32% | 0.00% | New | Q1 2026 | |
| $405K | 1.31% | 0.01% | New | Q1 2026 | |
| $380K | 1.23% | Not reported | New | Q1 2026 | |
| $375K | 1.21% | 0.00% | New | Q1 2026 | |
| $365K | 1.18% | 0.00% | New | Q1 2026 | |
| $359K | 1.16% | 0.00% | Not reported | Q4 2024 | |
| $356K | 1.15% | 0.00% | New | Q1 2026 | |
| $348K | 1.13% | 0.01% | New | Q1 2026 | |
| $313K | 1.01% | 0.01% | New | Q1 2026 | |
| $302K | 0.98% | 0.01% | Not reported | Q4 2024 | |
| $291K | 0.94% | 0.00% | +36.4% | Q4 2024 | |
| $271K | 0.88% | 0.00% | Not reported | Q4 2024 | |
| $227K | 0.73% | 0.00% | Not reported | Q4 2024 | |
| $223K | 0.72% | 0.00% | Not reported | Q2 2020 | |
| $223K | 0.72% | Not reported | New | Q1 2026 | |
| $221K | 0.71% | 0.04% | Not reported | Q4 2024 | |
| $218K | 0.71% | 0.20% | +682.1% | Q4 2025 | |
| $211K | 0.68% | 0.00% | +17.7% | Q4 2024 | |
| $167K | 0.54% | Not reported | New | Q1 2026 | |
| $111K | 0.36% | 0.00% | New | Q1 2026 | |
| $62.4K | 0.20% | 0.41% | New | Q1 2026 | |
| $51.9K | 0.17% | 0.01% | New | Q1 2026 | |
| $49.1K | 0.16% | 0.02% | -48.2% | Q4 2024 | |
| $35.4K | 0.11% | 0.48% | New | Q1 2026 | |
| Q4 2025Reported Feb 17, 202635 positions | |||||
| $645K | 7.60% | 0.00% | New | Q4 2025 | |
| CACWANClearwater Analytics Holdings, Inc. | $482K | 5.68% | Not reported | New | Q4 2025 |
| ATFOLDAmicus Therapeutics, Inc. | $427K | 5.03% | 0.01% | New | Q4 2025 |
| $404K | 4.76% | 0.00% | New | Q4 2025 | |
| $371K | 4.37% | 0.02% | Not reported | Q1 2025 | |
| $368K | 4.34% | 0.00% | New | Q4 2025 | |
| $357K | 4.21% | Not reported | New | Q4 2025 | |
| $347K | 4.09% | 0.00% | New | Q4 2025 | |
| $329K | 3.88% | 0.00% | Not reported | Q3 2019 | |
| $305K | 3.59% | 0.00% | New | Q4 2025 | |
| $300K | 3.54% | Not reported | Not reported | Q4 2024 | |
| $284K | 3.35% | Not reported | New | Q4 2025 | |
| $258K | 3.04% | 0.00% | -31.6% | Q3 2025 | |
| $255K | 3.01% | 0.03% | Not reported | Q4 2024 | |
| $236K | 2.78% | 0.02% | +80.0% | Q3 2025 | |
| $225K | 2.65% | 0.03% | New | Q4 2025 | |
| $224K | 2.64% | 0.00% | New | Q4 2025 | |
| TTGNATegna Inc | $221K | 2.61% | Not reported | Not reported | Q4 2022 |
| $217K | 2.56% | 0.00% | New | Q4 2025 | |
| $217K | 2.55% | 0.00% | +13.3% | Q4 2024 | |
| ABRNAMAvidity Biosciences, Inc. | $216K | 2.55% | 0.00% | New | Q4 2025 |
| $212K | 2.50% | 0.00% | -8.3% | Q4 2024 | |
| $208K | 2.45% | 0.00% | New | Q4 2025 | |
| $197K | 2.32% | 0.14% | -1.9% | Q3 2025 | |
| $196K | 2.31% | 0.00% | Not reported | Q1 2025 | |
| $182K | 2.14% | 0.01% | New | Q4 2025 | |
| $166K | 1.96% | 0.04% | Not reported | Q4 2024 | |
| $153K | 1.80% | 0.01% | Not reported | Q4 2024 | |
| $134K | 1.57% | 0.00% | New | Q4 2025 | |
| $109K | 1.28% | 0.03% | New | Q4 2025 | |
| $74.7K | 0.88% | 0.05% | New | Q4 2025 | |
| KKOREKORE Group Holdings, Inc. | $59K | 0.70% | 0.08% | New | Q4 2025 |
| $55K | 0.65% | 0.00% | Not reported | Q4 2024 | |
| $49K | 0.58% | 0.01% | +25.0% | Q4 2024 | |
| $3K | 0.04% | Not reported | New | Q4 2025 | |
| Q3 2025Reported Nov 14, 202518 positions | |||||
| IINFAInformatica LLC | $994K | 16.04% | 0.04% | Not reported | Q4 2024 |
| $495K | 7.99% | Not reported | New | Q3 2025 | |
| PPGREParamount Group, Inc. | $418K | 6.75% | 0.03% | New | Q3 2025 |
| $406K | 6.55% | 0.00% | Not reported | Q4 2024 | |
| $400K | 6.45% | 0.01% | New | Q3 2025 | |
| $386K | 6.23% | 0.11% | New | Q3 2025 | |
| $299K | 4.82% | 0.01% | New | Q3 2025 | |
| $266K | 4.30% | 0.00% | New | Q3 2025 | |
| $230K | 3.71% | 0.00% | New | Q3 2025 | |
| $229K | 3.69% | 0.00% | Not reported | Q4 2024 | |
| $227K | 3.67% | 0.01% | New | Q3 2025 | |
| $214K | 3.45% | 0.14% | New | Q3 2025 | |
| $209K | 3.38% | 0.00% | Not reported | Q4 2024 | |
| $165K | 2.67% | 0.01% | New | Q3 2025 | |
| $162K | 2.61% | 0.02% | New | Q3 2025 | |
| $128K | 2.06% | 0.01% | New | Q3 2025 | |
| $118K | 1.90% | 0.01% | Not reported | Q1 2025 | |
| $65.2K | 1.05% | 0.00% | Not reported | Q4 2024 | |
Premium opens every quarter this fund has filed